Literature DB >> 21304495

Enhancers of adeno-associated virus AAV2 transduction via high throughput siRNA screening.

Alexis J Wallen1, Gregory A Barker, David E Fein, Huiyan Jing, Scott L Diamond.   

Abstract

Intracellular barriers to adeno-associated virus (AAV) transduction may limit gene delivery. We screened a short interfering RNA (siRNA) library targeting 5,520 genes to help identify pathways that modulate AAV transduction of human endothelium. In replicate screening, 50 pools (three siRNAs per gene) resulted in greater than eightfold reporter gene expression enhancement. Single siRNA confirmation tests demonstrated that at least one siRNA from each of the top 10 pools provided greater than twofold enhancement. Several siRNAs when used together resulted in additive effects and two of the most potent siRNA sequences were enhancers in cultured airway epithelium. However, enhanced transduction was not correlated with mRNA knockdown by quantitative real time PCR, indicating an off-target mechanism. In fact, four of the five most potent siRNAs contained a consensus hexamer region 5'-UGUUUC-3' at positions 2-7 of the antisense strand. The point mutation U4A within this region (but not mutations at positions 1 or 14) disrupted transduction enhancement, indicating a microRNA (miRNA)-like mechanism. Transcription profiling indicated that the hexamer also resulted in perturbation of the interferon pathway via reduced interferon-induced protein 44-like (IFI44L), interferon-inducible myxovirus resistance 1 (MX1), and interferon-induced protein with tetratricopeptide repeats (IFIT5) mRNAs. Direct interferon (α, β, and ω) receptor 2 (IFNAR2) knockdown resulted in greater than twofold transduction enhancement. In addition to providing insight into AAV biology and enhanced transduction, the results demonstrate certain beneficial siRNA off-target effects.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21304495      PMCID: PMC3129788          DOI: 10.1038/mt.2011.4

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  39 in total

Review 1.  Initial and innate responses to viral infections--pattern setting in immunity or disease.

Authors:  C A Biron
Journal:  Curr Opin Microbiol       Date:  1999-08       Impact factor: 7.934

Review 2.  Eukaryotic initiation factor eIF2.

Authors:  S R Kimball
Journal:  Int J Biochem Cell Biol       Date:  1999-01       Impact factor: 5.085

Review 3.  The host type I interferon response to viral and bacterial infections.

Authors:  Andrea K Perry; Gang Chen; Dahai Zheng; Hong Tang; Genhong Cheng
Journal:  Cell Res       Date:  2005-06       Impact factor: 25.617

4.  Robust statistical methods for hit selection in RNA interference high-throughput screening experiments.

Authors:  Xiaohua Douglas Zhang; Xiting Cindy Yang; Namjin Chung; Adam Gates; Erica Stec; Priya Kunapuli; Dan J Holder; Marc Ferrer; Amy S Espeseth
Journal:  Pharmacogenomics       Date:  2006-04       Impact factor: 2.533

5.  3' UTR seed matches, but not overall identity, are associated with RNAi off-targets.

Authors:  Amanda Birmingham; Emily M Anderson; Angela Reynolds; Diane Ilsley-Tyree; Devin Leake; Yuriy Fedorov; Scott Baskerville; Elena Maksimova; Kathryn Robinson; Jon Karpilow; William S Marshall; Anastasia Khvorova
Journal:  Nat Methods       Date:  2006-03       Impact factor: 28.547

6.  Antitumor efficacy of AAV-mediated systemic delivery of interferon-beta.

Authors:  C J Streck; P V Dickson; C Y C Ng; J Zhou; M M Hall; J T Gray; A C Nathwani; A M Davidoff
Journal:  Cancer Gene Ther       Date:  2006-01-01       Impact factor: 5.987

7.  Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions.

Authors:  C Summerford; R J Samulski
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

8.  Selective and rapid uptake of adeno-associated virus type 2 in brain.

Authors:  J S Bartlett; R J Samulski; T J McCown
Journal:  Hum Gene Ther       Date:  1998-05-20       Impact factor: 5.695

9.  siRNA-mediated off-target gene silencing triggered by a 7 nt complementation.

Authors:  Xiaoyu Lin; Xiaoan Ruan; Mark G Anderson; Jeffrey A McDowell; Paul E Kroeger; Stephen W Fesik; Yu Shen
Journal:  Nucleic Acids Res       Date:  2005-08-09       Impact factor: 16.971

10.  A computational study of off-target effects of RNA interference.

Authors:  Shibin Qiu; Coen M Adema; Terran Lane
Journal:  Nucleic Acids Res       Date:  2005-03-30       Impact factor: 16.971

View more
  7 in total

1.  Adeno-associated virus 2 infection requires endocytosis through the CLIC/GEEC pathway.

Authors:  Mathieu Nonnenmacher; Thomas Weber
Journal:  Cell Host Microbe       Date:  2011-12-15       Impact factor: 21.023

Review 2.  Intracellular transport of recombinant adeno-associated virus vectors.

Authors:  M Nonnenmacher; T Weber
Journal:  Gene Ther       Date:  2012-02-23       Impact factor: 5.250

Review 3.  Host determinants of adeno-associated viral vector entry.

Authors:  Sirika Pillay; Jan E Carette
Journal:  Curr Opin Virol       Date:  2017-06-30       Impact factor: 7.090

Review 4.  Intracellular trafficking of adeno-associated virus (AAV) vectors: challenges and future directions.

Authors:  Jalish M Riyad; Thomas Weber
Journal:  Gene Ther       Date:  2021-03-03       Impact factor: 4.184

5.  The SUMOylation Pathway Restricts Gene Transduction by Adeno-Associated Viruses.

Authors:  Christina Hölscher; Florian Sonntag; Katharina Henrich; Qingxin Chen; Jürgen Beneke; Petr Matula; Karl Rohr; Lars Kaderali; Nina Beil; Holger Erfle; Jürgen A Kleinschmidt; Martin Müller
Journal:  PLoS Pathog       Date:  2015-12-01       Impact factor: 6.823

Review 6.  The Interplay between Adeno-Associated Virus and its Helper Viruses.

Authors:  Anita F Meier; Cornel Fraefel; Michael Seyffert
Journal:  Viruses       Date:  2020-06-19       Impact factor: 5.048

7.  Genome-wide RNAi screening identifies host restriction factors critical for in vivo AAV transduction.

Authors:  Miguel Mano; Rudy Ippodrino; Lorena Zentilin; Serena Zacchigna; Mauro Giacca
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-24       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.